FI960516A0 - Substituerade bifenylsulfonamidendotelinantagonister - Google Patents

Substituerade bifenylsulfonamidendotelinantagonister

Info

Publication number
FI960516A0
FI960516A0 FI960516A FI960516A FI960516A0 FI 960516 A0 FI960516 A0 FI 960516A0 FI 960516 A FI960516 A FI 960516A FI 960516 A FI960516 A FI 960516A FI 960516 A0 FI960516 A0 FI 960516A0
Authority
FI
Finland
Prior art keywords
biphenylsulfonamide
substituted
endothelin antagonists
endothelin
antagonists
Prior art date
Application number
FI960516A
Other languages
English (en)
Finnish (fi)
Other versions
FI960516A (sv
Inventor
Natesan Murugesan
Joel C Barrish
Philip D Stein
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/384,066 external-priority patent/US5760038A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI960516A0 publication Critical patent/FI960516A0/sv
Publication of FI960516A publication Critical patent/FI960516A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI960516A 1995-02-06 1996-02-05 Substituerade bifenylsulfonamidendotelinantagonister FI960516A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/384,066 US5760038A (en) 1995-02-06 1995-02-06 Substituted biphenyl sulfonamide endothelin antagonists
SG1996000999A SG46218A1 (en) 1995-02-06 1996-02-06 Substituted biphenyl sulfonamide endothelin antagonists

Publications (2)

Publication Number Publication Date
FI960516A0 true FI960516A0 (sv) 1996-02-05
FI960516A FI960516A (sv) 1996-08-07

Family

ID=26665074

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960516A FI960516A (sv) 1995-02-06 1996-02-05 Substituerade bifenylsulfonamidendotelinantagonister

Country Status (11)

Country Link
EP (1) EP0725067A1 (sv)
JP (1) JPH08245600A (sv)
CN (1) CN1060172C (sv)
CA (1) CA2168154A1 (sv)
CZ (1) CZ29296A3 (sv)
FI (1) FI960516A (sv)
HU (1) HUP9600256A3 (sv)
IL (1) IL116916A (sv)
NO (1) NO305559B1 (sv)
PL (1) PL183283B1 (sv)
SG (1) SG46218A1 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
DE122006000068I1 (de) * 1995-04-04 2007-05-10 Encysive Pharmaceuticals Inc Thienyl-,Furyl-,Pyrrolyl-und Biphenylsulfonamide und Derivate zur Modulation der Endothelin-Aktivität
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) * 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
SG87053A1 (en) * 1996-02-20 2002-03-19 Bristol Myers Squibb Co High melt polymorth of the compound n-(3,4-dimethyl-5-isoxazolyl)-4'- (2-oxazolyl) [1,1'-biphenyl]-2-sulfonamide
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
WO1998033781A1 (en) * 1997-01-30 1998-08-06 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
ATE292129T1 (de) 1997-04-28 2005-04-15 Encysive Pharmaceuticals Inc Sulfonamide für die behandlung von störungen durch endothelin vermittelt
NZ506877A (en) * 1998-03-31 2002-04-26 Tanabe Seiyaku Co Benzenesulfonamide compounds useful in treating dysuria
GEP20033114B (en) * 1998-07-06 2003-11-25 Bristol Myers Squibb Co Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists, Method for Their Production and Pharmaceutical Compositions Containing the Same
AU3718900A (en) 1999-03-19 2000-10-09 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
US9196844B2 (en) * 2012-06-01 2015-11-24 Semiconductor Energy Laboratory Co., Ltd. Method of synthesizing pyrazine derivative, and light-emitting element, light-emitting device, electronic device, and lighting device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
PL312650A1 (en) 1996-08-19
IL116916A (en) 2000-09-28
NO305559B1 (no) 1999-06-21
IL116916A0 (en) 1996-05-14
HUP9600256A2 (en) 1997-10-28
HUP9600256A3 (en) 1998-08-28
EP0725067A1 (en) 1996-08-07
NO960473L (no) 1996-08-07
CN1138581A (zh) 1996-12-25
JPH08245600A (ja) 1996-09-24
NO960473D0 (no) 1996-02-05
CA2168154A1 (en) 1996-08-07
PL183283B1 (pl) 2002-06-28
CN1060172C (zh) 2001-01-03
CZ29296A3 (en) 1996-09-11
HU9600256D0 (en) 1996-03-28
SG46218A1 (en) 1998-02-20
FI960516A (sv) 1996-08-07

Similar Documents

Publication Publication Date Title
FI961804A (sv) Endotelinreceptorantagonister
FI960953A0 (sv) Endotelinreceptorantagonister
FI960516A (sv) Substituerade bifenylsulfonamidendotelinantagonister
NO943190L (no) Sulfonamid-endothelin-antagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
PT805813E (pt) Antagonistas de vasopressina triciclicos
DE69327720D1 (de) Endothelin rezeptor antagonisten
DE59609887D1 (de) Substituierte cyanophenyluracile
DK0699069T3 (da) Endothelinreceptorantagonister
NO20000542L (no) Endothelin-antagonister
BR9507220A (pt) Antagonistas de receptores de endotelina
DE59610332D1 (de) Substituierte aminouracile
DE69636597D1 (de) Endothelin rezeptor antagonisten
NO963131D0 (no) Endotelinreseptorantagonister
BR9608890A (pt) N-metilenotiouréias substituídas
NO963213D0 (no) Endotelinreseptorantagonister
NO944013D0 (no) Endothelin-antagonister II
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
DE69626986D1 (de) Endothelinrezeptorantagonist
BR9603432A (pt) Antagonistas de receptores de endotelina
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
DE69628924D1 (de) Endothelinrezeptorantagonisten
DE59607958D1 (de) Substituierte phenyluracile
KR970702876A (ko) 뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)